跨导管大动脉替换后永久导电障碍的患病率和临床结果
Takahiko Kai1, Masaki Izumo1, Masahiro Sekiguchi1
1Department of Cardiology, St. Marianna University School of Medicine, Kawasaki, Japan.
Journal of cardiology
|May 7, 2025
概括
通过导管大动脉置换 (TAVR) 后的新导电干扰可以解决. 永久性或先前存在的导电问题增加了心力衰竭住院的风险,但恢复后的障碍影响有限.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏电生理学 心脏电生理学
背景情况:
- 新发病的导电障碍是跨导管大动脉更换 (TAVR) 后的一个重大问题.
- 这些干扰可能会随着时间的推移而消失,因此需要了解它们的恢复模式和临床影响.
研究的目的:
- 为了评估TAVR后传导干扰的恢复.
- 评估传导障碍恢复与临床结果之间的关联,包括死亡率和心力衰竭住院治疗.
主要方法:
- 对780名TAVR患者的回顾性分析.
- 在TAVR后六个月的导电状态基础上分成两组:没有干扰,恢复干扰,永久干扰和程序前干扰.
- 主要结局:全因死亡率和心力衰竭住院治疗;次要结局:心脏损伤的变化.
主要成果:
- 28%的患者在TAVR后出现了新的导电障碍;其中45%的患者在六个月后出现了永久的导电障碍.
- 永久性和程序前导电障碍与显著更高的心力衰竭住院率 (HR分别为3.63和2.50) 有关.
- 恢复过来的导电障碍的预后与没有导电障碍的预后相当;永久性和程序前障碍加剧了心脏损伤.
结论:
- 在TAVR后的永久性和程序前导电障碍与心力衰竭住院的增加有关.
- 恢复过来的导电障碍的预后影响似乎有限,这表明这些患者的预后结果有利.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...


